Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-054035

Urovant Sciences Ltd. · UROV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Oct 1, 2018
Accepted (ET)
Oct 3, 2018 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001740547

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Shares, par value $0.000037453 per shareF1,F2,F3Oct 1, 2018P2,678,571$14.00A22,703,669ISee Explanation

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit 24.1 - Power of Attorney (incorporated by reference in Form 3 filed by the Reporting Persons on September 26, 2018)